Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)-Reference-Cited by-同舟云学术

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)

Published:2014-04 Issue:5 Volume:59 Page:1726-1737
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Watashi Koichi¹,Sluder Ann²,Daito Takuji¹²,Matsunaga Satoko³,Ryo Akihide³,Nagamori Shushi⁴,Iwamoto Masashi¹,Nakajima Syo¹,Tsukuda Senko¹⁵,Borroto‐Esoda Katyna²,Sugiyama Masaya⁶,Tanaka Yasuhito⁷,Kanai Yoshikatsu⁴,Kusuhara Hiroyuki⁸,Mizokami Masashi⁶,Wakita Takaji¹

Affiliation:

1. Department of Virology IINational Institute of Infectious DiseasesTokyo Japan

2. SCYNEXIS, Inc.Durham NC USA

3. Department of MicrobiologyYokohama City University School of MedicineYokohama Japan

4. Osaka University Graduate School of MedicineOsaka Japan

5. Micro‐signaling Regulation Technology UnitRIKEN Center for Life Science TechnologiesWako Japan

6. Research Center for Hepatitis and ImmunologyNational Center for Global Health and MedicineIchikawa Japan

7. Department of Virology and Liver UnitNagoya City University Graduate School of Medicinal SciencesNagoya Japan

8. University of Tokyo Graduate School of Pharmaceutical SciencesTokyo Japan

Funder

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science, and Technology, Japan

Ministry of Health, Labour, and Welfare, Japan

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.26982

Reference50 articles.

1. Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach

2. Viral determinants and host immune responses in the pathogenesis of HBV infection

3. Hepatitis B virus resistance to antiviral drugs: where are we going?

4. HBV life cycle and novel drug targets

5. Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting NTCP for liver disease treatment: A promising strategy;Journal of Pharmaceutical Analysis;2024-09

2. Bile acid–microbiota crosstalk in hepatitis B virus infection;Journal of Gastroenterology and Hepatology;2024-05-09

3. Hepatitis B virus-targeting sodium taurocholate cotransporting polypeptide mediates HBV infection and damage in human renal podocytes;Microbiology Spectrum;2024-03-05

4. Role of sodium taurocholate cotransporting polypeptide (NTCP) in HBV-induced hepatitis: Opportunities for developing novel therapeutics;Biochemical Pharmacology;2024-01

5. Path to Cure Hepatitis B: How Far Are We?;Livestock Diseases and Management;2024